Specialty-level and unit-level profitability analysis: ARPOB, cost per occupied
Specialty-level and unit-level profitability analysis: ARPOB, cost per occupied bed, and contribution by department and procedure
ALOS and bed-occupancy revenue modelling, specialty-wise P&L, insurance and TPA collections tracking, capex for equipment, and NABH-aligned financial reporting for hospitals and diagnostic chains.
Hospital economics turn on a handful of powerful ratios: average revenue per occupied bed against cost per occupied bed, occupancy against capacity, and the payor mix that determines how much of billed revenue is actually realised. Insurance and government scheme reimbursements arrive late and discounted; doctor engagement models — minimum guarantees, revenue shares, fee-for-service — shape both cost structure and clinical behaviour. Capital intensity is brutal: equipment and bed capacity absorb crores years before utilisation justifies them. Diagnostics adds volume economics — per-test contribution, B2B versus B2C realisation, and hub-and-spoke logistics. Few industries punish financial imprecision so quickly.
Leading providers manage ARPOB against cost per occupied bed at specialty level, engineer payor mix deliberately, structure doctor engagement models that align clinical and financial outcomes, and subject every equipment and bed-expansion decision to utilisation-based appraisal. Diagnostics leaders know per-test economics by centre and channel.
Specialty-level clarity tells you exactly where to add beds, equipment, and clinical talent — so capital flows to the service lines that build both medical reputation and institutional surplus.